依替福林
化合物
依替福林(INN:etilefrine)是一种强心剂,用作抗低血压药物。它是3-羟基苯乙醇胺系列的拟交感胺,用于治疗神经、心血管、内分泌或代谢引起的直立性低血压。静脉输注该化合物可增加人和实验动物的心输出量、每搏输出量、静脉回流和血压,这表明其可刺激α和β肾上腺素受体。[1][2][3][4][5]然而,体外研究表明依替福林对β1(心脏)的亲和力比对β2肾上腺素受体的亲和力高得多。[6]
临床资料 | |
---|---|
其他名称 | (2-乙氨基-1-(3'-羟基苯基)乙醇 |
AHFS/Drugs.com | 国际药品名称 |
ATC码 | |
识别信息 | |
| |
CAS号 | 709-55-7 |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.010.829 |
化学信息 | |
化学式 | C10H15NO2 |
摩尔质量 | 181.24 g·mol−1 |
3D模型(JSmol) | |
手性 | 外消旋混合物 |
| |
|
参考资料
- ^ Nusser E, Donath H, Russ W. [On the circulatory action of depot-Effortil in patients with hypotonic regulation circulator disorders]. Die Medizinische Welt. August 1965, 32: 1824–7. PMID 5320529 (German).
- ^ Mellander S. Comparative effects of acetylcholine, butyl-nor-synephrine (Vasculat), noradrenaline, and ethyl-adrainol (Effonti) on resistance, capacitance, and precapillary sphincter vessels and capillary filtration in cat skeletal muscle. Angiologica. 1966, 3 (2): 77–99. PMID 4380206. doi:10.1159/000157650.
- ^ von Limbourg P, Just H, Lang KF. Positive inotrope Wirkung von Etilefrinhydrochlorid (EffortilR). Kardiol. 1973, 586: 1.
- ^ Tarnow J, Brückner JB, Eberlein HG, Patschke D, Reinecke A, Schmicke P. Experimentelle Untersuchungen zur Beeinflussung der Hämodynamik in tiefer Halothannarkose durch Dopamin, Glucagon, Effortil, Noradrenalin und Dextran. Der Anaesthesist. 1973, 22: 8–15.
- ^ Carrera AL, Aguilera AM. Algunos effectos circulatorios de la m− oxifenil etanol etilmaina y sus modificaciones por el bloqueo α y β adrenergico.. Arch. Inst. Cardiol. (Mexico). 1973, 43: 279–287.
- ^ Offermeier J, Dreyer AC. A comparison of the effects of noradrenaline, adrenaline and some phenylephrine derivatives on alpha-, beta- and beta- adrenergic receptors. South African Medical Journal = Suid-Afrikaanse Tydskrif vir Geneeskunde. March 1971, 45 (10): 265–7. PMID 4396765.
外部链接
- Etilefrine. PubChem. [2024-03-25]. (原始内容存档于2013-10-04).
- Etilefrine. Kegg. [2024-03-25]. (原始内容存档于2024-03-25).